• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625315003
Device Problem High Test Results (2457)
Patient Problems Thrombosis/Thrombus (4440); Insufficient Information (4580)
Event Date 01/01/2023
Event Type  Injury  
Event Description
The initial reporter alleged questionable results from coaguchek xs meter serial number (b)(4) and alleged an adverse event for the patient.The reporter alleged measurement differences between the coaguchek xs with different test strip batches compared to a laboratory on an unknown date last year.No specific results or dates could be provided.The patient allegedly had several mini-thromboses as a result.The patient¿s toe was reportedly discolored and the tissue died.The patient¿s toe was allegedly removed this year.The date of the event is an approximation.No specific date or other information was provided.The therapeutic range was 2.0-3.0 inr.This mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
The meter was requested for return.The test strips were no longer available.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." per product labeling: "the presence of anti-phospholipid antibodies (apas) such as lupus antibodies (la) may lead to prolonged clotting times, i.E., they may cause false-high inr values.If you have or suspect that you have apas, discontinue testing until you discuss with your physician.".
 
Manufacturer Narrative
The returned meter was measured with the retention test strips 57261210 in comparison to the current test strip master lot.For this purpose, two human blood samples from marcumar donors and internal reference meters were used.Reference meter: test 1: 3.5 inr, test 2: 2.5 inr.Customer meter: test 1: 3.3 inr, test 2: 2.4 inr.All inr values were within the specified target ranges, confirming the functionality of the coaguchek measuring system.No error messages occurred.The returned customer material and retention material comply with specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16714383
MDR Text Key313042398
Report Number1823260-2023-01212
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number04625315003
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CORTISONE
Patient Outcome(s) Other; Hospitalization;
-
-